- Home
- ASRT vs BLUE Comparison
ASRT vs BLUE Comparison
Compare ASRT & BLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- BLUE
- Stock Information
- Founded
- ASRT 1995
- BLUE 1992
- Country
- ASRT United States
- BLUE United States
- Employees
- ASRT N/A
- BLUE N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- BLUE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASRT Health Care
- BLUE Health Care
- Exchange
- ASRT Nasdaq
- BLUE Nasdaq
- Market Cap
- ASRT 85.1M
- BLUE 75.8M
- IPO Year
- ASRT 1997
- BLUE 2013
- Fundamental
- Price
- ASRT $0.83
- BLUE $6.96
- Analyst Decision
- ASRT Strong Buy
- BLUE Hold
- Analyst Count
- ASRT 4
- BLUE 9
- Target Price
- ASRT $3.19
- BLUE $49.14
- AVG Volume (30 Days)
- ASRT 419.9K
- BLUE 199.3K
- Earning Date
- ASRT 03-10-2025
- BLUE 03-25-2025
- Dividend Yield
- ASRT N/A
- BLUE N/A
- EPS Growth
- ASRT N/A
- BLUE N/A
- EPS
- ASRT N/A
- BLUE N/A
- Revenue
- ASRT $125,763,000.00
- BLUE $53,120,000.00
- Revenue This Year
- ASRT N/A
- BLUE $145.88
- Revenue Next Year
- ASRT $1.84
- BLUE $239.89
- P/E Ratio
- ASRT N/A
- BLUE N/A
- Revenue Growth
- ASRT N/A
- BLUE 144.50
- 52 Week Low
- ASRT $0.73
- BLUE $5.80
- 52 Week High
- ASRT $1.80
- BLUE $38.40
- Technical
- Relative Strength Index (RSI)
- ASRT 45.42
- BLUE 39.64
- Support Level
- ASRT $0.78
- BLUE $7.25
- Resistance Level
- ASRT $0.85
- BLUE $8.22
- Average True Range (ATR)
- ASRT 0.03
- BLUE 0.53
- MACD
- ASRT 0.00
- BLUE -0.11
- Stochastic Oscillator
- ASRT 56.14
- BLUE 8.81
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About BLUE bluebird bio Inc.
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.